mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.004 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
0.15 |
0.006 |
mRNA |
MLN4924 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.007 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.007 |
mRNA |
KIN001-102 |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.008 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.008 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.009 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.009 |
mRNA |
(5Z)-7-Oxozeaenol |
GDSC1000 |
pan-cancer |
AAC |
0.08 |
0.009 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.087 |
0.009 |